Form 4: Timberland Bancorp Director Robert Drugge Acquires and Disposes of Shares
SEC Filing
Robert Drugge, a director of Timberland Bancorp, reports acquiring 645 shares of common stock and holding 40,018 shares following the transaction on September 24, 2024.
Summary
- Robert Drugge, a director at Timberland Bancorp, filed a Form 4 detailing changes in beneficial ownership.
- On September 24, 2024, Drugge acquired 645 shares of Timberland Bancorp's common stock.
- The acquisition was related to a restricted stock award that was granted on the same day.
- These shares will vest equally over three years.
- Following the reported transaction, Drugge beneficially owns 40,018 shares of Timberland Bancorp.
- The form indicates that Drugge is a director of the company.
Sentiment
Score: 6
Explanation: The document is a neutral report of stock transactions. The acquisition of shares by a director is mildly positive, suggesting confidence, but it's a routine filing.
Positives
- The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The restricted stock award vests over three years, suggesting a continued relationship between the director and the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/24/2024 | Date of the transaction and grant of restricted stock award. |
| 09/26/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.